Influence of platelet reactivity and inflammation on peri-procedural myonecrosis in East Asian patients undergoing elective percutaneous coronary intervention

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 427-435

  Jeong, Young Hoon ^a,b   Tantry, Udaya S ^b   Min, Ji Hyun ^a   Park, Yongwhi ^a   Navarese, Eliano Pio ^c   Koh, Jin Sin ^a   Park, Jeong Rang ^a   Hwang, Seok Jae ^a   Kho, Eun Ha ^a   Bliden, Kevin P ^b   Kwak, Choong Hwan ^a   Hwang, Jin Yong ^a   Kim, Sunjoo ^a   Gurbel, Paul A ^b  

^a Gyeongsang National University   (South Korea)

^b SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cholesterol; Inflammation; Myonecrosis; Percutaneous coronary intervention; Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; COLLAGEN; CREATINE KINASE MB; TROPONIN I;

ADULT; AGED; ARTICLE; BALLOON DILATATION; BARE METAL STENT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DOSE RESPONSE; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE AGGREGATION;

CHOLESTEROL; INFLAMMATION; MYONECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PLATELETS; FAR EAST; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PREOPERATIVE CARE; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 84883786348     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.132     Document Type: Article

References (41)

1. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 2574 2609
2. G.G. Babu, J.M. Walker, D.M. Yellon, and D.J. Hausenloy Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection Eur Heart J 32 2011 23 31
3. A.J. Lansky, and G.W. Stone Periprocedural myocardial infarction: prevalence, prognosis, and prevention Circ Cardiovasc Interv 3 2010 602 610
4. V. Novack, M. Pencina, and D.J. Cohen Troponin criteria for myocardial infarction after percutaneous coronary intervention Arch Intern Med 172 2012 502 508
5. L. Testa, W.J. Van Gaal, and G.G. Biondi Zoccai Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition QJM 102 2009 369 378
6. D.N. Feldman, L. Kim, A.G. Rene, R.M. Minutello, G. Bergman, and S.C. Wong Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis Catheter Cardiovasc Interv 77 2011 1020 1030
7. L. Bonello, U.S. Tantry, and R. Marcucci Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
8. Y.H. Jeong, U.S. Tantry, and I.S. Kim Effect of CYP2C19*2 and*3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin Circ Cardiovasc Interv 4 2011 585 594
9. D.W. Park, S.W. Lee, and S.C. Yun A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation J Am Coll Cardiol 58 2011 2630 2639
10. S.G. Ahn, S.H. Lee, and J.H. Yoon Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction JACC Cardiovasc Interv 5 2012 259 267
11. D.J. Kereiakes, and P.A. Gurbel Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention JACC Cardiovasc Interv 1 2008 111 121
12. P.A. Gurbel, K.P. Bliden, K.A. Zaman, J.A. Yoho, K.M. Hayes, and U.S. Tantry Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study Circulation 111 2005 1153 1159
13. T. Cuisset, M. Hamilos, and J. Sarma Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris Am J Cardiol 101 2008 1700 1703
14. P.A. Gurbel, K.P. Bliden, and J.F. Saucedo Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study J Am Coll Cardiol 53 2009 648 657
15. A. Perez de Prado, C. Cuellas, and A. Diego Influence of platelet reactivity and response to clopidogrel on myocardial damage following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome Thromb Res 124 2009 678 682
16. F. Mangiacapra, E. Barbato, and G. Patti Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention JACC Cardiovasc Interv 3 2010 318 323
17. J. Saw, C. Densem, and S. Walsh The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy JACC Cardiovasc Interv 1 2008 654 659
18. G. Yong, J. Rankin, and L. Ferguson Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial Am Heart J 157 2009 60.e1-9.
19. Y.G. Ko, J.W. Suh, and B.H. Kim Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention Am Heart J 161 2011 383 390
20. B.K. Kim, S.J. Oh, S.J. Yoon, D.W. Jeon, Y.G. Ko, and J.Y. Yang A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention Yonsei Med J 52 2011 717 726
21. G. Lippi, M. Franchini, and G. Targher Arterial thrombus formation in cardiovascular disease Nat Rev Cardiol 8 2011 502 512
22. A. Goldberg, L. Gruberg, and A. Roguin Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina Am Heart J 151 2006 1265 1270
23. H.S. Gurm, D.L. Bhatt, R. Gupta, S.G. Ellis, E.J. Topol, and M.S. Lauer Preprocedural white blood cell count and death after percutaneous coronary intervention Am Heart J 146 2003 692 698
24. K. Thygesen, J.S. Alpert, and H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
25. J.B. Selvanayagam, I. Porto, and K. Channon Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging Circulation 111 2005 1027 1032
26. C.C. Lim, W.J. van Gaal, and L. Testa With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention J Am Coll Cardiol 57 2011 653 661
27. I.S. Kim, Y.H. Jeong, and M.K. Kang Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y12 assay J Thromb Thrombolysis 30 2010 486 495
28. 12 antagonism Platelets 22 2011 619 625
29. L. Badimon, R.F. Storey, and G. Vilahur Update on lipids, inflammation and atherothrombosis Thromb Haemost 105 Suppl. 1 2011 S34 S42
30. G. Stone Assessment of Dual Antiplatelet Therapy with Drug Eluting Stents (ADAPT-DES) trial. Presented at Transcatheter Cardiovascular Therapeutics 2011 at San Francisco, USA J Am Coll Cardiol 59 2012 E292
31. B. Bigalke, S. Lindemann, and R. Ehlers Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome Eur Heart J 27 2006 2165 2169
32. V. Krishna, G.A. Diamond, and S. Kaul The role of platelet reactivity and genotype testing in the prevention of atherothrombotic cardiovascular events remains unproven Circulation 125 2012 1288 1303
33. Y.H. Jeong, Y. Park, K.P. Bliden, U.S. Tantry, and P.A. Gurbel High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype Heart 98 2012 343
34. P.A. Gurbel, and U.S. Tantry Platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents Circulation 125 2012 1276 1287
35. A.M. Gori, R. Marcucci, and R. Paniccia Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function Thromb Haemost 100 2008 1136 1145
36. H. Iso, R. Cui, C. Date, S. Kikuchi, A. Tamakoshi JACC Study Group C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study Atherosclerosis 207 2009 291 297
37. M. Kinoshita, S. Matsumura, K. Sueyoshi, S. Ogawa, and K. Fukuda Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention? Circ J 71 2007 1225 1228
38. P. Tricoci, Z. Huang, and C. Held TRACER Investigators. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
39. C. Kimmelstiel, P. Zhang, and N.K. Kapur Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention Circ Cardiovasc Interv 4 2011 171 179
40. G. Patti, C.P. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
41. G.Y. Lip, and A.D. Blann Thrombogenesis and fibrinolysis in acute coronary syndromes. Important facets of a prothrombotic or hypercoagulable state? J Am Coll Cardiol 36 2000 2044 2046